Horm Metab Res 2006; 38(7): 447-451
DOI: 10.1055/s-2006-947842
Original Basic

© Georg Thieme Verlag KG Stuttgart · New York

Haplotypes in the Promoter Region of the ADIPOQ Gene are Associated with Increased Diabetes Risk in a German Caucasian Population

P. E. H. Schwarz 1 , S. Govindarajalu 1 , W. Towers 1 , 3 , U. Schwanebeck 2 , S. Fischer 1 , F. Vasseur 4 , S. R. Bornstein 1 , J. Schulze 1
  • 1III° Medical Clinic Department of Endocrinopathies and Metabolic Diseases
  • 2Department of Biometrics, Carl Gustav Carus Medical School, Dresden University of Technology, Dresden, Germany
  • 3Center for Genome Research, Potchefstroom University for CHE, Pretoria, South Africa
  • 4CNRS UMR 8090 and University Hospital of Lille, France
Further Information

Publication History

Received 29 March 2006

Accepted after revision 20 April 2006

Publication Date:
24 August 2006 (online)

Abstract

Adiponectin, which is encoded by the ADIPOQ gene, has been shown to modulate insulin sensitivity and glucose homeostasis. Plasma adiponectin levels are decreased in type 2 diabetes and obesity. Genetic variations within the ADIPOQ gene are associated with decreased adiponectin hormone levels. To analyze specific single-nucleotide polymorphisms (SNPs) and their association with T2D, 365 German subjects with T2D and 323 control subjects were screened. Three common SNPs - +45T>G in exon 2, and 2 promoter variants SNPs -11391G>A and -11377C>G - were analyzed. We found that the variant allele of SNP -11391G>A was significantly more frequent in the diabetic patient group than in the control group (p=0.003). Carrying the haplotype of SNP -11391A and SNP -11377C was associated with a 1.50-fold (p=0.03) increase in diabetes risk. The combination of the A-C haplotype and the G-C haplotype was associated with significantly elevated diabetes risk (OR=2.82 (95% CI: 1.35-5.91), p=0.006) after correction for BMI and age. Our observations suggest that diploid combinations of haplotype in the adiponectin gene promoter region contribute to the genetic risk of T2D in individuals from a German Caucasian population.

References

  • 1 Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy.  Lancet. 2005;  365 1333-1346
  • 2 Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic.  Nature. 2001;  414 782-787
  • 3 Stefan N, Stumvoll M. Adiponectin-its role in metabolism and beyond.  Horm Metab Res. 2002;  34 469-474
  • 4 Tschritter O. et al. . Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.  Diabetes. 2003;  52 239-243
  • 5 Kumada M. et al. . Association of hypoadiponectinemia with coronary artery disease in men.  Arterioscler Thromb Vasc Biol. 2003;  23 85-89
  • 6 Weyer C. et al. . Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.  J Clin Endocrinol Metab. 2001;  86 1930-1935
  • 7 Ferris WF. et al. . The relationship between insulin sensitivity and serum adiponectin levels in three population groups.  Horm Metab Res. 2005;  37 695-701
  • 8 Yamauchi T. et al. . The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.  Nat Med. 2001;  7 941-946
  • 9 Vionnet N. et al. . Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.  Am J Hum Genet. 2000;  67 1470-1480
  • 10 Menzaghi C. et al. . A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.  Diabetes. 2002;  51 2306-2312
  • 11 Stumvoll M. et al. . Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes.  Diabetes. 2002;  51 37-41
  • 12 Vasseur F. et al. . Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians.  Hum Mol Genet. 2002;  11 2607-2614
  • 13 Hara K. et al. . Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population.  Diabetes. 2002;  51 536-540
  • 14 Lacquemant C. et al. . The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus.  Diabet Med. 2004;  21 776-781
  • 15 Ezenwaka CE. et al. . Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus.  Horm Metab Res. 2004;  36 238-242
  • 16 Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.  Mol Biol Evol. 1995;  12 921-927
  • 17 Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data.  Am J Hum Genet. 2001;  68 978-989
  • 18 Zhao JH. et al. . GENECOUNTING: haplotype analysis with missing genotypes.  Bioinformatics. 2002;  18 1694-1695
  • 19 Xie X, Ott J. Testing linkage disequilibrium between a disease gene and marker loci.  Am J Hum Genet. 1993;  53 1107
  • 20 Gu HF. et al. . Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians.  Diabetes. 2004;  53 Suppl 1 31-35

Correspondence

Dr. med. Peter Egbert Hermann SchwarzIII° 

Medical Clinic·Carl Gustav Carus Medical School·Dresden University of Technology

Fetscherstrasse 74·01307 Dresden·Germany

Phone: +49/351/458 27 15

Fax: +49/351/458 87 03

Email: pschwarz@rcs.urz.tu-dresden.de